• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[农村人口(科尔多瓦省拉维多利亚)抗流感疫苗接种的成本效益分析]

[Cost-effectiveness analysis of antigrippal vaccination in a rural population (La Victoria, Cordoba)].

作者信息

Gavira F J, Lardinois R

机构信息

Distrito Sanitario de Atención Primaria de Lucena, Córdoba.

出版信息

Med Clin (Barc). 1990 May 26;94(20):777-81.

PMID:2118204
Abstract

After 4 successive campaigns of influenza vaccination (1984-1988) in La Victoria (Córdoba), a village with a population of 1750, the economic cost-effectiveness was estimated on the basis of the effectiveness attributable to the vaccine and that actually found. The mean cost of an influenza case amounted to 69,295 pesetas. The vaccine coverage increased during the study period from 20% to 30% in the general population and from 63% to 78% in the risk population. The effectiveness of vaccination, variable among years, was as a rule lower than expected. Cost-effectiveness was not related with the magnitude of the coverage, but increased proportionally with the morbidity rate.

摘要

在科尔多瓦省的拉维多利亚村(该村有1750人)开展了连续4次流感疫苗接种活动(1984 - 1988年)之后,根据疫苗的归因效力以及实际发现的效力对经济成本效益进行了估算。一例流感病例的平均成本为69295比塞塔。在研究期间,普通人群的疫苗接种覆盖率从20%升至30%,高危人群的覆盖率从63%升至78%。疫苗接种的效力每年各不相同,通常低于预期。成本效益与覆盖率大小无关,但与发病率成比例增加。

相似文献

1
[Cost-effectiveness analysis of antigrippal vaccination in a rural population (La Victoria, Cordoba)].[农村人口(科尔多瓦省拉维多利亚)抗流感疫苗接种的成本效益分析]
Med Clin (Barc). 1990 May 26;94(20):777-81.
2
Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.确定流感疫苗接种在欧盟25个国家内对健康和经济的影响。
Vaccine. 2006 Nov 17;24(47-48):6812-22. doi: 10.1016/j.vaccine.2006.07.042. Epub 2006 Aug 4.
3
Cost-effectiveness of influenza vaccination in working-age cancer patients.在职癌症患者中流感疫苗接种的成本效益
Cancer. 2007 Jun 1;109(11):2357-64. doi: 10.1002/cncr.22670.
4
The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.澳大利亚针对50至64岁成年人的全民流感疫苗接种计划的成本效益。
Vaccine. 2008 Apr 16;26(17):2142-53. doi: 10.1016/j.vaccine.2008.01.050. Epub 2008 Feb 20.
5
The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain.50至64岁成年人流感疫苗接种的成本效益:西班牙基于模型的分析
Vaccine. 2007 Sep 28;25(39-40):6900-10. doi: 10.1016/j.vaccine.2007.07.033. Epub 2007 Aug 6.
6
[Anti-influenza vaccination for active persons (25-64 years): a cost-benefit study].[针对活跃人群(25 - 64岁)的抗流感疫苗接种:一项成本效益研究]
Rev Epidemiol Sante Publique. 1992;40(5):285-95.
7
Influenza vaccination: cost-effective health care for the older adult?流感疫苗接种:对老年人而言是否具有成本效益的医疗保健措施?
J Qual Clin Pract. 1997 Mar;17(1):3-11.
8
Influence of clinical case definitions with differing levels of sensitivity and specificity on estimates of the relative and absolute health benefits of influenza vaccination among healthy working adults and implications for economic analyses.具有不同敏感性和特异性水平的临床病例定义对健康在职成年人流感疫苗接种相对和绝对健康益处估计的影响及其对经济分析的意义。
Virus Res. 2004 Jul;103(1-2):3-8. doi: 10.1016/j.virusres.2004.02.005.
9
Cost-effectiveness of influenza vaccination of healthy children.健康儿童接种流感疫苗的成本效益
Vaccine. 2006 Jun 5;24(23):4934-41. doi: 10.1016/j.vaccine.2006.03.057. Epub 2006 Apr 7.
10
Cost-effectiveness of a recommendation of universal mass vaccination for seasonal influenza in the United States.美国季节性流感普遍人群疫苗接种推荐的成本效益分析。
Value Health. 2011 Sep-Oct;14(6):800-11. doi: 10.1016/j.jval.2011.03.005.

引用本文的文献

1
Vaccines for preventing influenza in the elderly.用于预防老年人流感的疫苗。
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD004876. doi: 10.1002/14651858.CD004876.pub4.
2
Economic evaluation of influenza vaccination and economic modelling. Can results be pooled?
Pharmacoeconomics. 1996;9 Suppl 3:67-72. doi: 10.2165/00019053-199600093-00015.
3
Weekly monitoring of influenza impact in Belgium (1993-1995).
Pharmacoeconomics. 1996;9 Suppl 3:34-7; discussion 50-3. doi: 10.2165/00019053-199600093-00009.
4
Influenza vaccines. A reappraisal of their use.流感疫苗。对其使用的重新评估。
Drugs. 1997 Dec;54(6):841-56. doi: 10.2165/00003495-199754060-00004.